Lueder M. Fels

Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias

C. Rowe, C. Masters, H. Tochon-Danguy, 2011, The Journal of Nuclear Medicine.

A Novel Fluorescent Imaging Agent for Diffuse Optical Tomography of the Breast: First Clinical Experience in Patients

Marjolein van der Voort, Bernhard Brendel, Tim Nielsen, 2009, Molecular Imaging and Biology.

The establishment of a network of European human research tissue banks

Robert Combes, Timo Ylikomi, Jan van der Valk, 2004, Cell and Tissue Banking.

Evaluation of possible drug–drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)

B. Hamm, A. Huppertz, M. Schultze-Mosgau, 2011, Journal of magnetic resonance imaging : JMRI.

Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study

J. Smith, I. Gashaw, Lueder M. Fels, 2022, Clinical Pharmacokinetics.

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study

S. Birring, J. Smith, T. Hummel, 2021, The European respiratory journal.

Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC)

S. Birring, A. Morice, A. Turner, 2020 .

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension

W. Seeger, S. Rosenkranz, H. Ghofrani, 2017, Pulmonary circulation.

Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women

Lueder M. Fels, B. Lindenthal, S. Klein, 2023, Clinical Pharmacokinetics.